Palatin Technologies, Inc. Insider Trading

PTN

Last 12 months

Insiders sold 9K and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Jun 2025.

Net open-market

−9K

0 buys · 1 sale

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

0 / 1

executives and directors

Last open-market buy

Jun 2025

Jun 13, 2025

Get an email when PTN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Dec 24, 2025	Stephen T Wills Executive VP and CFO/COO	Sold10b5-1 plan	565	$16.74	9K	0.9%	Form 4
Jun 13, 2025	Stephen T Wills Executive VP and CFO/COO	Bought	1,500	—	—	<0.1%	Form 4
Jun 13, 2025	Carl Spana President and CEO	Bought	1,500	—	—	<0.1%	Form 4
Jun 13, 2025	Alan W Dunton Director	Bought	200	—	—	<0.1%	Form 4
May 7, 2025	Robert K Deveer Jr Director	Bought	100,000	$0.10	10K	263%	Form 4

Dec 24, 202510b5-1 plan
Stephen T Wills
Executive VP and CFO/COO · sold 565 at $16.74
9K
0.9% of stake
Jun 13, 2025
Stephen T Wills
Executive VP and CFO/COO · bought 1,500
—
<0.1% of stake
Jun 13, 2025
Carl Spana
President and CEO · bought 1,500
—
<0.1% of stake
Jun 13, 2025
Alan W Dunton
Director · bought 200
—
<0.1% of stake
May 7, 2025
Robert K Deveer Jr
Director · bought 100,000 at $0.10
10K
263% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PTN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with PTN

CompareIntrinsic value

HOOKHookipa Pharma Inc.

No recent price20

ACRSAclaris Therapeutics, Inc.

$3.68-1.60%10

ISCOInternational Stem Cell Corporation

$0.14+0.00%29

COYACoya Therapeutics Inc.

$3.08-0.96%10

PGENPrecigen Inc.

$5.06-3.71%0

PULMPulmatrix Inc.

$1.52+14.29%40

IRDOpus Genetics Inc.

$4.27+8.65%10

ADAGAdagene Inc.

$2.41+2.55%25

Spot a number that looks wrong? Check it in PTN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing PTN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.